Dextrose 50% Injection – SHORTAGE
Availability of dextrose 50% vials and pre-filled syringes are on manufacture back order limiting supply here at AAMC and across the country.
Please click here to view details and recommendations.
For questions or interest in being added to the drug shortage distribution list, email Jared Calish, clinical coordinator, at jcalish@AAHS.org.
AAMC Critical Drug Shortage Update for February.
Due to a variety of reasons, AAMC is currently facing a shortage of several drugs. Please click here the view the updated list. If you are interested in being added to the drug shortage distribution list, email Jared Calish, clinical coordinator, at firstname.lastname@example.org.
Due to a variety of reasons AAMC is currently facing a shortage of methylprednisolone injection which is used in various places throughout AAMC. Read more>>
Update as of 4:38pm, January 30, 2013
- Methylprednisolone and dexamethasone are both critical supply:
- Pharmacy is nearly out of both methylprednisolone and dexamethasone injection house wide
- Pharmacy is expecting both products to arrive sometime tomorrow
- The amount arriving will only help but not resolve the critical shortage of both medications
- More information will come out once both drugs are in hand
- Please refer to the chart below to convert from one glucocorticoid to another – a pharmacist may page the prescriber to alert them to change to whatever is on hand as well
The most critical items are: Erythromycin: A limited amount of vials are left (~15) with none available at the wholesale level at this time. Medications out of stock include atracurium, caffeine benzoate IV, methyldopa IV, pancuronium, phentolamine, prochlorperazine IV, and secretin. Items that have been resolved include foscarnet IV (available on special order), hydromorphone PCA, isosorbide dinitrate (5 and 10mg available, no 20mg tablets), phytonadione IV, and sulfamethozole/trimethoprim IV (Bactrim) with a limited amount available and the IV form still restricted to ID. View the complete shortage list here.
The most critical items are listed below with the complete list including the ones below attached. Please forward to your colleagues since many may not see this post.
- Succinylcholine – supply is limited <200 vials available in house with none available at the wholesale level. Please consider alternatives and conserve use as much as possible.
- Furosemide IV – this shortage affects all sizes. A recommendation is to use IV bumetanide if needed or oral/liquid furosemide. Currently only a few days’ supply remains on hand with no supply available at the wholesaler and manufacturer level.
- Bumetanide IV – limited amount available due to shortage of furosemide. Please try to limit/conserve IV doses and consider oral as needed. Pharmacy will be drawing up standard doses from bulk vials in the next few days to help provide medication for use.
- Morphine and hydromorphone PCA – supply is still limited, please conserve
- Medications out of stock include: atracurium, Foscarnet, lidocaine PF 1.5%, methyldopa IV, pancuronium, phentolamine, prochlorperazine IV, secretin and Bactrim IV
- Resolved – chloroprocaine 2 & 3%, methotrexate IV, multivitamin IV, pantoprazole IV, and tetracaine ophthalmic solution.
Below are AAMC’s critical drug shortages as of June 11:
1. Furosemide IV: This shortage affects all sizes. It is recommended to use IV bumetanide if needed or oral/liquid furosemide. Currently, only a few days’ supply remain on hand with no supply available at the wholesaler and manufacturer level.
2. Morphine and hydromorphone PCA: Supply is still limited; please conserve.
3. Medications out of stock include atracurium, chloroprocaine 2%, etomidate, lidocaine PF 1.5%, methyldopa IV, pancuronium, phentolamine, prochlorperazine IV, secretin, and Bactrim IV.
4. Resolved: Bumetanide (Bumex) IV and chloroprocaine 3%.
Questions, please contact Jared S. Calish, PharmD; pharmacy clinical coordinator, at email@example.com.
Click here for a list of all shortages